Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Use of a Regression Model to Study Host-Genomic Determinants of Phage Susceptibility in MRSA.

Zschach H, Larsen MV, Hasman H, Westh H, Nielsen M, Międzybrodzki R, Jończyk-Matysiak E, Weber-Dąbrowska B, Górski A.

Antibiotics (Basel). 2018 Jan 29;7(1). pii: E9. doi: 10.3390/antibiotics7010009.

2.

Metagenomic Analysis of Therapeutic PYO Phage Cocktails from 1997 to 2014.

Villarroel J, Larsen MV, Kilstrup M, Nielsen M.

Viruses. 2017 Nov 3;9(11). pii: E328. doi: 10.3390/v9110328.

3.

A Bacterial Analysis Platform: An Integrated System for Analysing Bacterial Whole Genome Sequencing Data for Clinical Diagnostics and Surveillance.

Thomsen MC, Ahrenfeldt J, Cisneros JL, Jurtz V, Larsen MV, Hasman H, Aarestrup FM, Lund O.

PLoS One. 2016 Jun 21;11(6):e0157718. doi: 10.1371/journal.pone.0157718. eCollection 2016.

4.

HostPhinder: A Phage Host Prediction Tool.

Villarroel J, Kleinheinz KA, Jurtz VI, Zschach H, Lund O, Nielsen M, Larsen MV.

Viruses. 2016 May 4;8(5). pii: E116. doi: 10.3390/v8050116.

5.

What Can We Learn from a Metagenomic Analysis of a Georgian Bacteriophage Cocktail?

Zschach H, Joensen KG, Lindhard B, Lund O, Goderdzishvili M, Chkonia I, Jgenti G, Kvatadze N, Alavidze Z, Kutter EM, Hasman H, Larsen MV.

Viruses. 2015 Dec 12;7(12):6570-89. doi: 10.3390/v7122958.

6.

Reads2Type: a web application for rapid microbial taxonomy identification.

Saputra D, Rasmussen S, Larsen MV, Haddad N, Sperotto MM, Aarestrup FM, Lund O, Sicheritz-Pontén T.

BMC Bioinformatics. 2015 Nov 25;16:398. doi: 10.1186/s12859-015-0829-0.

7.

Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users.

Harboe ZB, Larsen MV, Ladelund S, Kronborg G, Konradsen HB, Gerstoft J, Larsen CS, Pedersen C, Pedersen G, Obel N, Benfield T.

Clin Infect Dis. 2014 Oct 15;59(8):1168-76. doi: 10.1093/cid/ciu558. Epub 2014 Jul 17.

PMID:
25038114
8.

Improving biotech education through gamified laboratory simulations.

Bonde MT, Makransky G, Wandall J, Larsen MV, Morsing M, Jarmer H, Sommer MO.

Nat Biotechnol. 2014 Jul;32(7):694-7. doi: 10.1038/nbt.2955. No abstract available.

PMID:
25004234
10.

Benchmarking of methods for genomic taxonomy.

Larsen MV, Cosentino S, Lukjancenko O, Saputra D, Rasmussen S, Hasman H, Sicheritz-Pontén T, Aarestrup FM, Ussery DW, Lund O.

J Clin Microbiol. 2014 May;52(5):1529-39. doi: 10.1128/JCM.02981-13. Epub 2014 Feb 26.

11.

Internet-based solutions for analysis of next-generation sequence data.

Larsen MV.

J Clin Microbiol. 2013 Sep;51(9):3162. doi: 10.1128/JCM.01348-13. No abstract available.

12.

Bioinformatics identification of antigenic peptide: predicting the specificity of major MHC class I and II pathway players.

Lund O, Karosiene E, Lundegaard C, Larsen MV, Nielsen M.

Methods Mol Biol. 2013;960:247-260. doi: 10.1007/978-1-62703-218-6_19.

PMID:
23329492
13.

Genotyping using whole-genome sequencing is a realistic alternative to surveillance based on phenotypic antimicrobial susceptibility testing.

Zankari E, Hasman H, Kaas RS, Seyfarth AM, Agersø Y, Lund O, Larsen MV, Aarestrup FM.

J Antimicrob Chemother. 2013 Apr;68(4):771-7. doi: 10.1093/jac/dks496. Epub 2012 Dec 11.

PMID:
23233485
14.

Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletion.

Perez CL, Milush JM, Buggert M, Eriksson EM, Larsen MV, Liegler T, Hartogensis W, Bacchetti P, Lund O, Hecht FM, Nixon DF, Karlsson AC.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):602-12. doi: 10.1089/AID.2012.0171. Epub 2013 Jan 8.

15.

The cancer exome generated by alternative mRNA splicing dilutes predicted HLA class I epitope density.

Stranzl T, Larsen MV, Lund O, Nielsen M, Brunak S.

PLoS One. 2012;7(9):e38670. doi: 10.1371/journal.pone.0038670. Epub 2012 Sep 25.

16.

Impact of gender on the risk of AIDS-defining illnesses and mortality in Danish HIV-1-infected patients: a nationwide cohort study.

Thorsteinsson K, Ladelund S, Jensen-Fangel S, Larsen MV, Johansen IS, Katzenstein TL, Pedersen G, Storgaard M, Obel N, Lebech AM.

Scand J Infect Dis. 2012 Oct;44(10):766-75. Epub 2012 Jul 17.

PMID:
22803607
17.

Identification of acquired antimicrobial resistance genes.

Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV.

J Antimicrob Chemother. 2012 Nov;67(11):2640-4. doi: 10.1093/jac/dks261. Epub 2012 Jul 10.

18.

Hepatitis C viral load, genotype 3 and interleukin-28B CC genotype predict mortality in HIV and hepatitis C-coinfected individuals.

Clausen LN, Astvad K, Ladelund S, Larsen MV, Schønning K, Benfield T.

AIDS. 2012 Jul 31;26(12):1509-16. doi: 10.1097/QAD.0b013e3283553581.

PMID:
22555162
19.

Identification of a novel UTY-encoded minor histocompatibility antigen.

Mortensen BK, Rasmussen AH, Larsen ME, Larsen MV, Lund O, Braendstrup P, Harndahl M, Rasmussen M, Buus S, Stryhn A, Vindeløv L.

Scand J Immunol. 2012 Aug;76(2):141-50. doi: 10.1111/j.1365-3083.2012.02708.x.

20.

Multilocus sequence typing of total-genome-sequenced bacteria.

Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, Jelsbak L, Sicheritz-Pontén T, Ussery DW, Aarestrup FM, Lund O.

J Clin Microbiol. 2012 Apr;50(4):1355-61. doi: 10.1128/JCM.06094-11. Epub 2012 Jan 11.

21.

Human leukocyte antigen (HLA) class I restricted epitope discovery in yellow fewer and dengue viruses: importance of HLA binding strength.

Lund O, Nascimento EJ, Maciel M Jr, Nielsen M, Larsen MV, Lundegaard C, Harndahl M, Lamberth K, Buus S, Salmon J, August TJ, Marques ET Jr.

PLoS One. 2011;6(10):e26494. doi: 10.1371/journal.pone.0026494. Epub 2011 Oct 19. Erratum in: PLoS One. 2011;6(11). doi:10.1371/annotation/254c9f39-1c6b-4f48-a947-b4ed931642e7.

22.

Major but differential decline in the incidence of Staphylococcus aureus bacteraemia in HIV-infected individuals from 1995 to 2007: a nationwide cohort study*.

Larsen MV, Harboe ZB, Ladelund S, Skov R, Gerstoft J, Pedersen C, Larsen CS, Obel N, Kronborg G, Benfield T.

HIV Med. 2012 Jan;13(1):45-53. doi: 10.1111/j.1468-1293.2011.00937.x. Epub 2011 Aug 7.

23.

[Acute lymphatic leukaemia with eosinophilia in a younger man returning from a travel in the tropics--case report].

Larsen MV, Karstoft K, Andersen MK.

Ugeskr Laeger. 2011 May 9;173(19):1363-4. Danish.

PMID:
21561575
24.

Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.

Wang M, Tang ST, Stryhn A, Justesen S, Larsen MV, Dziegiel MH, Lewinsohn DM, Buus S, Lund O, Claesson MH.

Immunology. 2011 Apr;132(4):482-91. doi: 10.1111/j.1365-2567.2010.03383.x. Epub 2011 Feb 7.

25.

Identification of CD8+ T cell epitopes in the West Nile virus polyprotein by reverse-immunology using NetCTL.

Larsen MV, Lelic A, Parsons R, Nielsen M, Hoof I, Lamberth K, Loeb MB, Buus S, Bramson J, Lund O.

PLoS One. 2010 Sep 14;5(9):e12697. doi: 10.1371/journal.pone.0012697.

26.

Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.

Larsen MV, Omland LH, Gerstoft J, Røge BT, Larsen CS, Pedersen G, Obel N, Kronborg G.

Scand J Infect Dis. 2010 Dec;42(11-12):917-23. doi: 10.3109/00365548.2010.511258. Epub 2010 Sep 15.

PMID:
20840000
27.

HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses.

Wang M, Larsen MV, Nielsen M, Harndahl M, Justesen S, Dziegiel MH, Buus S, Tang ST, Lund O, Claesson MH.

PLoS One. 2010 May 7;5(5):e10533. doi: 10.1371/journal.pone.0010533.

28.

Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort study.

Larsen MV, Omland LH, Gerstoft J, Larsen CS, Jensen J, Obel N, Kronborg G.

Addiction. 2010 Mar;105(3):529-35. doi: 10.1111/j.1360-0443.2009.02827.x.

PMID:
20402997
29.

NetCTLpan: pan-specific MHC class I pathway epitope predictions.

Stranzl T, Larsen MV, Lundegaard C, Nielsen M.

Immunogenetics. 2010 Jun;62(6):357-68. doi: 10.1007/s00251-010-0441-4. Epub 2010 Apr 9.

30.

Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation.

Larsen ME, Kornblit B, Larsen MV, Masmas TN, Nielsen M, Thiim M, Garred P, Stryhn A, Lund O, Buus S, Vindelov L.

Biol Blood Marrow Transplant. 2010 Oct;16(10):1370-81. doi: 10.1016/j.bbmt.2010.03.022. Epub 2010 Mar 28.

31.

Risk of high-level viraemia in HIV-infected patients on successful antiretroviral treatment for more than 6 months.

Engsig FN, Omland LH, Larsen MV, Rasmussen LD, Qvist T, Gerstoft J, Obel N.

HIV Med. 2010 Aug;11(7):457-61. doi: 10.1111/j.1468-1293.2009.00813.x. Epub 2010 Feb 9.

32.

Systematic characterisation of cellular localisation and expression profiles of proteins containing MHC ligands.

Juncker AS, Larsen MV, Weinhold N, Nielsen M, Brunak S, Lund O.

PLoS One. 2009 Oct 14;4(10):e7448. doi: 10.1371/journal.pone.0007448.

33.

Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital.

Larsen MV, Janner JH, Nielsen SD, Friis-Møller A, Ringbaek T, Lange P.

Scand J Infect Dis. 2009;41(1):26-32. doi: 10.1080/00365540802484828.

PMID:
18855228
34.

Cohort profile: the Danish HIV cohort study.

Obel N, Engsig FN, Rasmussen LD, Larsen MV, Omland LH, Sørensen HT.

Int J Epidemiol. 2009 Oct;38(5):1202-6. doi: 10.1093/ije/dyn192. Epub 2008 Sep 17. No abstract available.

PMID:
18799495
35.

Re-activation of bovine tuberculosis in a patient treated with infliximab.

Larsen MV, Sørensen IJ, Thomsen VØ, Ravn P.

Eur Respir J. 2008 Jul;32(1):229-31. doi: 10.1183/09031936.00125607.

36.

Broadly immunogenic HLA class I supertype-restricted elite CTL epitopes recognized in a diverse population infected with different HIV-1 subtypes.

Pérez CL, Larsen MV, Gustafsson R, Norström MM, Atlas A, Nixon DF, Nielsen M, Lund O, Karlsson AC.

J Immunol. 2008 Apr 1;180(7):5092-100.

37.

Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction.

Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M.

BMC Bioinformatics. 2007 Oct 31;8:424.

38.

Signal-averaged P wave duration and the long-term risk of permanent atrial fibrillation.

Dixen U, Larsen MV, Ravn L, Parner J, Jensen GB.

Scand Cardiovasc J. 2008 Feb;42(1):31-7.

PMID:
17943628
39.

CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.

Wang M, Lamberth K, Harndahl M, Røder G, Stryhn A, Larsen MV, Nielsen M, Lundegaard C, Tang ST, Dziegiel MH, Rosenkvist J, Pedersen AE, Buus S, Claesson MH, Lund O.

Vaccine. 2007 Apr 12;25(15):2823-31. Epub 2006 Dec 29.

PMID:
17254671
40.

Supplemental Content

Loading ...
Support Center